Back | Next |
home / stock / avxl / avxl message board
Subject | By | Source | When |
---|---|---|---|
I suspect he is one of the reasons | crescentmotor | investorshub | 07/24/2024 5:50:03 AM |
Youre trying to reason with a known FUD | Graniteguy | investorshub | 07/24/2024 3:56:58 AM |
I was aware of the high-level idea of | Anshu2 | investorshub | 07/24/2024 3:19:21 AM |
Seems that way | Kb1123 | investorshub | 07/24/2024 2:47:28 AM |
He or she is not even aware of that, | catdaddy | investorshub | 07/24/2024 2:47:02 AM |
So you dont give Anavex increased chances of | Kb1123 | investorshub | 07/24/2024 2:32:33 AM |
We have no information about Anavex's possible interaction | boi568 | investorshub | 07/24/2024 2:29:02 AM |
None of these trials were actually failed trials: | georgejjl | investorshub | 07/24/2024 2:28:44 AM |
Yes, I agree that EMA and FDA mostly | Anshu2 | investorshub | 07/24/2024 2:21:18 AM |
Avatar (though this was before 2022, I guess). | Anshu2 | investorshub | 07/24/2024 2:18:32 AM |
FDA is very anal about what constitutes trial | Anshu2 | investorshub | 07/24/2024 2:17:28 AM |
Dr. Marwan Sabbagh latest video regarding Anavex Life | georgejjl | investorshub | 07/24/2024 1:58:25 AM |
Multiple trial failures?? | Guzzi62 | investorshub | 07/24/2024 1:49:29 AM |
FYI, the EMA and the FDA agree about | boi568 | investorshub | 07/24/2024 1:48:25 AM |
Just another irrelevant AH, arent you? | catdaddy | investorshub | 07/24/2024 1:33:55 AM |
And what is your reasoning for the very | Kb1123 | investorshub | 07/24/2024 1:30:09 AM |
You are on this message board all the | Anshu2 | investorshub | 07/24/2024 1:24:51 AM |
I agree partly. I think its better than | Anshu2 | investorshub | 07/24/2024 1:20:57 AM |
Took a long time to respond, didnt it? | catdaddy | investorshub | 07/24/2024 1:05:48 AM |
Doc328: Do you believe that the following is | georgejjl | investorshub | 07/24/2024 1:00:20 AM |
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
2024-07-18 02:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental and neuropsyc...
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental, and neuropsyc...